For the Inventor, By the Inventor

Enter assignee name

Unichem Laboratories Limited

USPTO Granted Patents = 24

% Expired Patents = 29.2

EPO Patents = 12

Forward Citations = 11

Loading Chart...

Loading Chart...

51 inventors (with patents filed for the assignee):

Dhananjay Govind Sathe (21 out of 30 patents)

Arijit Das (11 out of 11 patents)

Yashwant S Surve (6 out of 6 patents)

4. Ramdas Ahire (5 out of 5 patents)

5. Pravin Kumar Maurya (3 out of 3 patents)

6. Sanjay Raikar (3 out of 3 patents)

7. Yogesh Subhash Patil (3 out of 3 patents)

8. Srikant V Pimple (3 out of 3 patents)

9. Nilesh L Bonde (2 out of 2 patents)

10. Ankush Sampat Kekan (2 out of 2 patents)

11. Dnyaneshwar V Gawas (2 out of 2 patents)

12. Bhushan Sudhakar Pandit (2 out of 11 patents)

13. Sudeep Kumar (2 out of 2 patents)

14. Saurabh Gupta (1 out of 118 patents)

15. Radha Achanath (1 out of 10 patents)

24 patents: Sort by Forward Citations

1. 12714737 - RECOMBINANT PROTEINS, COMPOSITIONS AND METHODS OF STABILIZATION THEREOF (2026-08-25),

2. 12564619 - STABLE FORMULATIONS OF RECOMBINANT PROTEINS (2026-03-03),

3. 12291733 - Process for the preparation of recombinant lectin protein (2025-05-06),

4. 11965003 - Recombinant lectin variants (2024-04-23),

5. 11891384 - Process for the preparation of Rivaroxaban involving novel intermediate (2024-02-06),

6. 11510909 - Pharmaceutical composition of apixaban (2022-11-29),

7. 11331283 - Pharmaceutical compositions comprising cinacalcet hydrochloride and one or more binders (2022-05-17),

8. 11266628 - Pharmaceutical compositions of apremilast (2022-03-08),

9. 11034683 - Process for the preparation of rivaroxaban involving novel intermediate (2021-06-15),

10. 11020390 - Bioequivalent pharmaceutical composition of vortioxetine hydrobromide (2021-06-01),

11. 10919855 - Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4yl]acetamide (2021-02-16),

12. 10836730 - Process for preparation and purification of vortioxetine hydrobromide (2020-11-17),

13. 10829450 - Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine (2020-11-10),

14. 10414720 - Process for the preparation of lacosamide (2019-09-17),

15. 10336753 - Process for the preparation of apixaban and intermediates thereof (2019-07-02),

Company Overview

Unichem Laboratories Limited is a prominent pharmaceutical company based in Mumbai, India, specializing in the development and manufacturing of a wide range of generic and branded formulations. The company focuses on various therapeutic areas, including cardiovascular, anti-infective, and central nervous system disorders. Unichem is committed to research and innovation, leveraging advanced technologies to enhance drug delivery and efficacy, while also expanding its global footprint in the pharmaceutical market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

24 Patents

#20 in Mumbai

#85 in India

#26,686 in the World

Unichem Laboratories Limited

Forward Citations = 11

51 inventors:

Dhananjay Govind Sathe (21 out of 30 patents)

Arijit Das (11 out of 11 patents)

Yashwant S Surve (6 out of 6 patents)

4. Ramdas Ahire (5 out of 5 patents)

5. Pravin Kumar Maurya (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Unichem Laboratories Limited. Retrieved from https://idiyas.com/company/unichem-laboratories

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…